EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Promising biomarkers of viral, bacterial and combined infections in humans

O. A. Dobrovolskaya, A. A. Lozhkov, S. M. Shishlyannikov, E. A. Elpaeva, A. V. Vasin

Medical academic journal · 29.12.2025 · 25 (4) · 5-20

DOI: 10.17816/maj698467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical academic journal, online erschienen am 29.12.2025. Verfasst von O. A. Dobrovolskaya und 4 weiteren Autor:innen. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral, bacterial, and mixed acute respiratory infections are a global health challenge, claiming more than four million lives annually. This condition is particularly prevalent among infants, children, and the elderly, with the highest rates reporting in low- and middle-income countries. Acute respiratory infections are primarily caused by bacterial and viral pathogens. Therefore, for effective treatment, the pathogen should be accurately identified. Currently, viral and bacterial respiratory infections are mainly differentiated by clinical symptoms, blood leukocyte count with differential, erythrocyte sedimentation rate, and various laboratory parameters. However, these diagnostic tools are inadequate for accurate diagnosis because of their limited sensitivity and frequent lack of specificity. Viral infections significantly increase the likelihood of secondary bacterial infections, which tend to present with a more severe clinical profile and higher rates of complications. The underlying mechanisms of bacterial superinfections are multifactorial processes that involve interactions between viruses, bacteria, and the host immune system. Differentiation between viral and bacterial infections in patients with respiratory diseases is a significant diagnostic challenge that often leads to overuse of antibiotics. Although current biomarkers can evaluate the likelihood of bacterial infections, reliable biomarkers for viral infections have yet to be discovered. This diagnostic gap highlights the need for new methods, especially given the strict antibiotic stewardship regulations in many countries, which require precise differential diagnoses to prevent antibiotic misuse.

Zitieren

APA

Dobrovolskaya, O. A., Lozhkov, A. A., Shishlyannikov, S. M., Elpaeva, E. A., & Vasin, A. V. (2025). Promising biomarkers of viral, bacterial and combined infections in humans. Medical academic journal, 25(4), 5-20. https://doi.org/10.17816/maj698467

Vancouver

Dobrovolskaya OA, Lozhkov AA, Shishlyannikov SM, Elpaeva EA, Vasin AV. Promising biomarkers of viral, bacterial and combined infections in humans. Medical academic journal. 2025;25(4):5-20. doi:10.17816/maj698467

BibTeX
@article{Dobrovolskaya2025,
  author = {Dobrovolskaya, O. A. and Lozhkov, A. A. and Shishlyannikov, S. M. and Elpaeva, E. A. and Vasin, A. V.},
  title = {Promising biomarkers of viral, bacterial and combined infections in humans},
  journal = {Medical academic journal},
  year = {2025},
  volume = {25},
  number = {4},
  pages = {5--20},
  doi = {10.17816/maj698467}
}
Kostenlos starten →